Intramuscular injection of botulinum toxin as an adjunct to arthrocentesis of the temporomandibular joint: Preliminary observations

British Journal of Oral and Maxillofacial Surgery

Volumn 41, Issue 5, 2003, Pages 351-352

  Freund, Brian J ^a,b   chwartz, M ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b Crown Institute   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; BOTULINUM TOXIN A;

ADULT; ARTHROCENTESIS; ARTHROTOMY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; JAW MOVEMENT; MALE; MASSETER MUSCLE; ORTHOTICS; PAIN ASSESSMENT; TEMPORALIS MUSCLE; TEMPOROMANDIBULAR JOINT DISORDER;

EID: 0242490791     PISSN: 02664356     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0266-4356(03)00129-3     Document Type: Article

References (5)

1. LeResche L, VonKorff MR, Fricton J et al. Research diagnostic criteria. J Craniomandib 1992; 6: 327-334.
2. Frost DE, Kendell BD. Part II. The use of arthrocentesis for treatment of temporomandibular joint disorders. J Oral Maxillofac Surg 1999; 57 (5): 583-587.
3. Melling J, Hambleton P, Shone CC. Clostridium botulinum toxins: nature and preparation for clinical use. Eye 1988; 2 (Pt 1): 16-23.
4. Watanabe Y, Bakheit A, McLellan D. A study of the effectiveness of botulinum toxin type A (Dysport) in the management of muscle spasticity. Disabil Rehabil: Int Multidiscip J 1998; 20 (2): 62-65.
5. Cui M, Aoki R. Botulinum toxin type-A reduces inflammatory pain in the rat formalin model. Cephalalgia 2000; 20 (4): 414.